Patents by Inventor Carole Gard

Carole Gard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10231990
    Abstract: The present invention relates to a sterile and/or decontaminated composition for topical use, including hyaluronic acid at a concentration of greater than or equal to 0.1 wt % relative to the total weight of the composition, at least one skin wound healing agent, optionally at least one plant extract, and at least one solvent. The invention also relates to a unit including such a composition, to a method for preparing such a composition, and to the uses thereof.
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: March 19, 2019
    Assignee: Horus Pharma
    Inventors: Claude Claret, Martine Claret, Carole Gard
  • Patent number: 9801899
    Abstract: The present invention relates to an oil-in-water emulsion comprising at least one mucomimetic polymer, at least one lipid of phospholipid type, at least one lipid other than the phospholipid, at least one stabilizing polymer, and a hydrophilic liquid, to an emulsion comprising an aqueous phase that contains at least one stabilizing polymer and at least one mucomimetic polymer, and an oily phase that contains at least one lipid of phospholipid type and a lipid other than the phospholipid, to a medicament comprising one of these emulsions, and to the use of one of these emulsions as an agent for restoring and/or replacing the lachrimal film or as a carrier for an active compound.
    Type: Grant
    Filed: April 21, 2011
    Date of Patent: October 31, 2017
    Assignee: Horus Pharma
    Inventors: Claude Claret, Martine Claret, Carole Gard, Nicola Lamprecht-Weissenborn
  • Publication number: 20130156867
    Abstract: The present invention relates to an oil-in-water emulsion comprising at least one mucomimetic polymer, at least one lipid of phospholipid type, at least one lipid other than the phospholipid, at least one stabilizing polymer, and a hydrophilic liquid, to an emulsion comprising an aqueous phase that contains at least one stabilizing polymer and at least one mucomimetic polymer, and an oily phase that contains at least one lipid of phospholipid type and a lipid other than the phospholipid, to a medicament comprising one of these emulsions, and to the use of one of these emulsions as an agent for restoring and/or replacing the lachrimal film or as a carrier for an active compound.
    Type: Application
    Filed: April 21, 2011
    Publication date: June 20, 2013
    Applicant: HORUS PHARMA
    Inventors: Claude Claret, Martine Claret, Carole Gard, Nicola Lamprecht-Weissenborn
  • Publication number: 20130129844
    Abstract: The present invention relates to a sterile and/or decontaminated composition for topical use, including hyaluronic acid at a concentration of greater than or equal to 0.1 wt % relative to the total weight of the composition, at least one skin wound healing agent, optionally at least one plant extract, and at least one solvent. The invention also relates to a unit including such a composition, to a method for preparing such a composition, and to the uses thereof.
    Type: Application
    Filed: July 28, 2011
    Publication date: May 23, 2013
    Applicant: HORUS PHARMA
    Inventors: Claude Claret, Martine Claret, Carole Gard